Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer. (Q37263115)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2008
edit
Language Label Description Also known as
English
Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer.
scientific article published on March 2008

    Statements

    Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit